A recent study highlights improper categorization and treatment of cough in India. It emphasizes the overuse of antibiotics and fixed-dose combinations, urging a scientific approach to evaluation and ...

Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

Trump administration to link children’s deaths with COVID-19 vaccine; Kenvue’s CEO lobbied RFK Jr.; NIH on track to spend its full budget by end of the month.

Recent health developments include the FDA's approval for Apple Watch hypertension features, Belgian contraceptive storage ...

The CEO of the company that makes Tylenol has directly pleaded with Robert F. Kennedy Jr. not to link the drug to autism.

The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human ...

Seeking Alpha's roundup of statements, announcements and remarks that could impact markets, sectors and individual stocks.

In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing ...

According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and ...

Kenvue's interim CEO Kirk Perry met Robert F. Kennedy Jr. to try and dissuade him from listing Tylenol as a potential cause ...

The oral health initiative is targeted at 750,000 elementary school students and their families in rural communities and ...